Drug Profile
Research programme: aldose reductase inhibitors - The Institute for Diabetes Discovery
Alternative Names: Aldose reductase inhibitors research programme - The Institute for Diabetes DiscoveryLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Institute for Diabetes Discovery LLC
- Developer Institute for Diabetes Discovery
- Class Small molecules
- Mechanism of Action Aldehyde reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetic neuropathies
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Diabetic-neuropathies in USA
- 30 Jun 2004 Preclinical trials in Diabetic neuropathies in USA (unspecified route)